Xeris Biopharma Holdings (XERS) Shares Outstanding (2020 - 2026)
Xeris Biopharma Holdings (XERS) Shares Outstanding (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 8.98 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.16 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 422.10 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 455,871.00 |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 100.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 497.70 Mn |
| 10 | Xeris Biopharma Holdings | 1.43 Bn | 1.32 Bn | 72.55 Mn | 170.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 170.52 Mn |
| Dec 31, 2025 | 160.43 Mn |
| Sep 30, 2025 | 163.65 Mn |
| Jun 30, 2025 | 159.46 Mn |
| Mar 31, 2025 | 152.45 Mn |
| Dec 31, 2024 | 146.77 Mn |
| Sep 30, 2024 | 148.99 Mn |
| Jun 30, 2024 | 148.35 Mn |
| Mar 31, 2024 | 140.51 Mn |
| Dec 31, 2023 | 137.67 Mn |
| Sep 30, 2023 | 138.06 Mn |
| Jun 30, 2023 | 137.34 Mn |
| Mar 31, 2023 | 137.14 Mn |
| Dec 31, 2022 | 135.63 Mn |
| Sep 30, 2022 | 135.95 Mn |
| Jun 30, 2022 | 135.53 Mn |
| Mar 31, 2022 | 135.03 Mn |
| Dec 31, 2021 | 79.03 Mn |
| Sep 30, 2021 | 66.50 Mn |
| Jun 30, 2021 | 66.37 Mn |